NCT04768192

Brief Summary

Walk recovery is one of the goals of rehabilitation programs in patients with acquired brain injury. Recent experiences have shown the effectiveness of rehabilitation programs including traditional physiotherapy in combination with robotic gait training systems (Lokomat). In this context, MRI can be used to assess the treatment effects on the muscular tissue, providing useful clinical indications for the optimization of the rehabilitation programs on the basis of the damage extension and the muscle characteristics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 18, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 24, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

February 24, 2021

Status Verified

February 1, 2021

Enrollment Period

1.9 years

First QC Date

February 18, 2021

Last Update Submit

February 22, 2021

Conditions

Outcome Measures

Primary Outcomes (8)

  • GMFM - T-pre

    Gross Motor Function Measures (GMFM) acquired before the beginning of the treatment. (Functional measure)

    The week before the beginning of the treatment

  • 6mwt - T-pre

    Six minute walking test (6mwt) performed before the beginning of the treatment. (Functional measure)

    The week before the beginning of the treatment

  • Ashowrth scale - T-pre

    Ashowrth scale acquired before the beginning of the treatment. (Functional measure)

    The week before the beginning of the treatment

  • Tardieu scale - T-pre

    Tardieu scale acquired before the beginning of the treatment. (Functional measure)

    The week before the beginning of the treatment

  • GMFM - T-post

    Gross Motor Function Measures (GMFM) acquired after the end of the treatment. (Functional measure)

    Within a week after the ent of the treatment

  • 6mwt - T-post

    Six minute walking test (6mwt) performed after the end of the treatment. (Functional measure)

    Within a week after the ent of the treatment

  • Ashowrth scale - T-post

    Ashowrth scale acquired performed after the end of the treatment. (Functional measure)

    Within a week after the ent of the treatment

  • Tardieu scale - T-post

    Tardieu scale acquired performed after the end of the treatment. (Functional measure)

    Within a week after the ent of the treatment

Secondary Outcomes (8)

  • WF - T-pre

    The week before the beginning of the treatment

  • FF - T-pre

    The week before the beginning of the treatment

  • FA - T-pre

    The week before the beginning of the treatment

  • MD - T-pre

    The week before the beginning of the treatment

  • WF - T-post

    Within a week after the end of the treatment

  • +3 more secondary outcomes

Study Arms (1)

Pediatric patients with acquired brain injury

Subjects with a acquired brain injury occurred in the last 10 months prior the beginning of the treatment

Procedure: Physical Rehabilitation without lokomatProcedure: Physical Rehabilitation with Lokomat

Interventions

Conventional physiotherapy is performed in 10 weekly sessions (45 minutes each) over 4 weeks(total 40 sessions). Specific exercises are administered to improve gait, balance and functional abilities focusing on: strengthening the gluteus and quadriceps muscles stretching the hip flexor and hamstrings muscles increasing static balance increasing dynamic balance increasing functional abilities improving ground gait going up and down the stairs. Physiotherapists can choose from a list of 25 standard exercises, according to some constraints: 1. strengthening exercises had to involve all the lower limb joints (no segmental intervention) 2. during each session, at least 4 out of the 7 categories above had to be delivered 3. the impossibility to perform any of the categories above during any session had to be recorded in the patient's treatment diary. Physiotherapists of the treatments group discuss patients' diaries during weekly meetings.

Also known as: Conventional physiotherapy
Pediatric patients with acquired brain injury

The rehabilitation protocol consists of 20 sessions of robotic training alternated with 20 sessions of conventional physiotherapy (CP). Each treatment is performed in 5 weekly sessions (45 minutes each) over 4 weeks. Robotic training aimed to recovery/improve walking capacity from the initial Gross Motor Function Classification System (GMFCS) level. It is performed using the Lokomat® (Hocoma AG, Volketswil, Switzerland) gait orthosis. Initial set ups includes 50% body weight unload, gait velocity adjusted on the patient individual capability (1.5 km/h on average) and 100% guidance force. Both weight unload and guidance force are gradually reduced across sessions according to patient recovery of muscle strength and allowing patients to work harden and move more freely. Children engagement, active participation and motivation were reinforced through frequent encouragement by therapists and performance feedback implemented in the exercise video-games.

Also known as: Lokomat
Pediatric patients with acquired brain injury

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population includes pediatric patients with acquired brain lesion occurred in the last 10 months prior the beginning of the treatment and showing deficit in the lower limbs movements due to the acquired lesion.

You may qualify if:

  • acquired brain lesion occurred in the last 10 months prior the beginning of the treatment
  • hemi or tetraparesis diagnosis following the brain lesion
  • thigh-bone length \> 21 cm
  • ability and willingness to follow instructions and communicate fear and pain

You may not qualify if:

  • severe contractures, fractures, bone instability or osteoporosis of the lower limbs
  • skin lesions in the lower limbs
  • thromboembolic or cardiovascular pathologies
  • aggression and self-aggressive behavior
  • orthopedic surgery and/or botulinum toxin injection in the 6 months prior to enrollment
  • cognitive and/or motor deficits prior to the injury
  • contraindications to MRI examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Scientific Institute IRCCS Eugenio Medea

Bosisio Parini, LC, 23842, Italy

RECRUITING

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Denis Peruzzo, PhD

    Research Institute IRCCS Eugenio Medea

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2021

First Posted

February 24, 2021

Study Start

January 1, 2020

Primary Completion

November 30, 2021

Study Completion

December 31, 2021

Last Updated

February 24, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations